William E. Gillanders
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Immunotherapy and Immune Responses 3
- Oncology 3
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Feng Gao (3 shared papers)Simone E. Muenst (3 shared papers)Savas Deniz Soysal (3 shared papers)Simon Peter Goedegebuure (1 shared paper)Ellen Christina Obermann (2 shared papers)Daniel Oertli (2 shared papers)William P. Weber (1 shared paper)Silvio Däster (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (2 papers)Annals of Oncology (1 paper)The Journal of Experimental Medicine (1 paper)British Journal of Cancer (1 paper)Transplantation (1 paper)
- Partner nations
- United StatesSwitzerlandAustria
In The Last Decade
William E. Gillanders
6 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 49
- Oncology 692
- Cancer Research 256
- Immunology 178
- Drug Discovery 1
- Otorhinolaryngology 12
Countries citing papers authored by William E. Gillanders
This map shows the geographic impact of William E. Gillanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Gillanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Gillanders more than expected).
Fields of papers citing papers by William E. Gillanders
This network shows the impact of papers produced by William E. Gillanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Gillanders. The network helps show where William E. Gillanders may publish in the future.
Co-authors
The 25 scholars most cited alongside William E. Gillanders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 480 | |
| 2 | 2013 | 293 | |
| 3 | 2017 | 198 | |
| 4 | 2013 | 109 | |
| 5 | 2023 | 22 | |
| 6 | 1997 | 4 |
About William E. Gillanders
William E. Gillanders is a scholar working on Immunology, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 6 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Breast Cancer Treatment Studies (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Oncology (692 citations), Cancer Research (256 citations), Immunology (178 citations), Drug Discovery (1 citation) and Otorhinolaryngology (12 citations). William E. Gillanders has collaborated with scholars based in United States, Switzerland and Austria. Frequent co-authors include Feng Gao, Simone E. Muenst, Savas Deniz Soysal, Simon Peter Goedegebuure, Ellen Christina Obermann, Daniel Oertli, William P. Weber, Silvio Däster, Paul Zajac and Raoul Andre Droeser. Their work appears in journals such as Breast Cancer Research and Treatment, Annals of Oncology, The Journal of Experimental Medicine, British Journal of Cancer and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.